Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Flaig

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Bioresearch Open Access|March 22, 2013
miR-125b Regulation of Androgen Receptor Signaling Via Modulation of the Receptor Complex Co-Repressor NCOR2Xiaoping Yang, Lynne Bemis, Lih-Jen Su, et al.
Cancer Medicine|December 30, 2015
Treatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world dataThomas W Flaig, Ravi C Potluri, Yvette Ng, et al.
International Journal of Cancer|January 19, 2007
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cellsThomas W Flaig, Lih-Jen Su, Gail Harrison, et al.
Prostate Cancer and Prostatic Diseases|November 19, 2022
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterationsCorbin J Eule, Thomas W Flaig, Katy Wong, et al.
Clinical Genitourinary Cancer|September 29, 2012
Thyroid dysfunction in patients treated with sunitinib or sorafenibJulia Clemons, Dexiang Gao, Mary Naam, et al.
JCO Oncology Practice|October 21, 2024
Effect of Prednisone Dosing on Mineralocorticoid-Related Side Effects With Abiraterone in Prostate CancerMaksym Goryachok, Andrew Nicklawsky, Hiba Ahmad, et al.
Oncology (Williston Park, N.Y.)|November 29, 2013
Collision renal cell papillary and medullary carcinoma in a 66-year-old manElaine T Lam, Elizabeth R Kessler, Thomas W Flaig, et al.
Urologic Oncology|February 4, 2018
Contribution of bladder cancer pathology assessment in planning clinical trialsCharles C Guo, Hikmat A Al-Ahmadie, Thomas W Flaig, et al.
F1000Research|March 24, 2018
Renal cell carcinoma: a review of biology and pathophysiologyShahzaib Nabi, Elizabeth R Kessler, Brandon Bernard, et al.
Urology Practice|May 5, 2023
Editorial CommentaryBrian Carter, Elijah Potokar, Rodrigo Rodrigues-Pessoa, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Bioresearch Open Access|March 22, 2013
miR-125b Regulation of Androgen Receptor Signaling Via Modulation of the Receptor Complex Co-Repressor NCOR2Xiaoping Yang, Lynne Bemis, Lih-Jen Su, et al.
Cancer Medicine|December 30, 2015
Treatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world dataThomas W Flaig, Ravi C Potluri, Yvette Ng, et al.
International Journal of Cancer|January 19, 2007
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cellsThomas W Flaig, Lih-Jen Su, Gail Harrison, et al.
Prostate Cancer and Prostatic Diseases|November 19, 2022
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterationsCorbin J Eule, Thomas W Flaig, Katy Wong, et al.
Clinical Genitourinary Cancer|September 29, 2012
Thyroid dysfunction in patients treated with sunitinib or sorafenibJulia Clemons, Dexiang Gao, Mary Naam, et al.
JCO Oncology Practice|October 21, 2024
Effect of Prednisone Dosing on Mineralocorticoid-Related Side Effects With Abiraterone in Prostate CancerMaksym Goryachok, Andrew Nicklawsky, Hiba Ahmad, et al.
Oncology (Williston Park, N.Y.)|November 29, 2013
Collision renal cell papillary and medullary carcinoma in a 66-year-old manElaine T Lam, Elizabeth R Kessler, Thomas W Flaig, et al.
Urologic Oncology|February 4, 2018
Contribution of bladder cancer pathology assessment in planning clinical trialsCharles C Guo, Hikmat A Al-Ahmadie, Thomas W Flaig, et al.
F1000Research|March 24, 2018
Renal cell carcinoma: a review of biology and pathophysiologyShahzaib Nabi, Elizabeth R Kessler, Brandon Bernard, et al.
Urology Practice|May 5, 2023
Editorial CommentaryBrian Carter, Elijah Potokar, Rodrigo Rodrigues-Pessoa, et al.
Pageof 15